Frain-Bell W
Department of Dermatology, Ninewells Hospital, Dundee, U.K.
Br J Dermatol. 1989 Nov;121(5):551-62. doi: 10.1111/j.1365-2133.1989.tb08186.x.
Cutaneous photosensitivity is a recognized side-effect of a number of commonly used groups of drugs, among which are the non-steroidal anti-inflammatory agents (NSAIDs) one of which, benoxaprofen, was withdrawn from use in 1982. The abnormal reaction of the skin to light usually occurs during the period of the systemic administration of the drug, but may with some drugs persist for longer, even for months. Chronic photosensitivity, i.e. 'persistent light reaction' of some years duration, continuing after the withdrawal of the primary cause, has so far only been reliably reported when the initial exposure of the skin to the photoactive substance has been by external contact and not following ingestion. A suggestion that photosensitivity could persist for a period of years as a sequel of initial benoxaprofen-induced photosensitivity was studied in a group of 42 subjects said to be affected in this way. The results failed to confirm the presence of persistent photosensitivity. It appeared that the probable explanation for the episodic abnormal reactions to light over the years since 1982 was the systemic administration of other photoactive drugs including a series of NSAIDs.
皮肤光敏性是许多常用药物公认的副作用,其中包括非甾体抗炎药(NSAIDs),其中一种药物苯恶洛芬于1982年停止使用。皮肤对光的异常反应通常发生在药物全身给药期间,但有些药物可能会持续更长时间,甚至数月。慢性光敏性,即持续数年的“持续性光反应”,在主要病因消除后仍持续存在,到目前为止,只有当皮肤最初接触光活性物质是通过外部接触而非摄入时,才得到可靠报道。一项针对42名据称受此影响的受试者的研究,探讨了光敏性是否可能作为最初苯恶洛芬诱导的光敏性的后遗症持续数年。结果未能证实存在持续性光敏性。看来,自1982年以来多年间对光的间歇性异常反应的可能解释是使用了包括一系列NSAIDs在内的其他光活性药物进行全身给药。